Practice Corner FAQ’s https://youtu.be/F7rlAIK27bc We receive regular questions about when to use modifiers. The video clip is an excerpt from our Annual Meeting 2024 presentation, “If It’s Not Documented, It Didn’t Happen.” In this clip, Teresa Thompson, BS, CPC, CMSCS,…
Targeted Molecular Therapies in Allergy and Rhinology
AAOA’s “Targeted Molecular Therapies in Allergy and Rhinology” (Damask C. et al) was published in the Bulletin.
The past decade has seen a rapid expansion in the use of biologic drugs for the treatment of numerous chronic inflammatory diseases.
Biologic drugs are monoclonal antibodies targeting specific Type ll inflammation molecular pathways for a variety of disease entities in the head and neck.
Read the article here:
